-
Revenue
$-3.38M
Net Income
-
Gross Margin
-
Op. Margin
$-950.01K
Free Cash Flow
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Operating Expenses | $836.25K | $902.60K | $688.80K | $1.96M | $647.79K | $541.14K |
| Research & Development | $485.68K | $471.47K | $350.71K | $1.02M | $410.81K | $291.39K |
| Operating Income | $-836.25K | $-902.60K | $-688.80K | $-1.96M | $-647.79K | $-541.14K |
| Other Income/Expense | $5.00 | $1.00 | $2.00 | $174.97K | $2.51M | $-7.68K |
| Net Income | $-422.55K | $-920.75K | $-243.83K | $-1.79M | $1.87M | $-548.82K |
| Basic EPS | -0.00 | -0.00 | -0.00 | -0.01 | 0.01 | -0.00 |
| Diluted EPS | -0.00 | -0.00 | -0.00 | -0.01 | 0.01 | -0.00 |
| Basic Shares Outstanding | 312.2M | 310.0M | 308.5M | 913K | 303.1M | 302.8M |
| Diluted Shares Outstanding | 312.2M | 310.0M | 308.5M | -13.3M | 316.9M | 302.8M |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $95.19K | $8.03K | $7.58K | $48.80K | $149.37K | $407.81K |
| Total Current Assets | $106.64K | $19.48K | $40.07K | $81.29K | $216.35K | $440.30K |
| Property Plant & Equipment | $585.41K | $615.75K | $641.99K | $539.65K | $498.17K | $527.84K |
| Total Assets | $1.49M | $1.45M | $1.48M | $1.39M | $1.49M | $1.31M |
| Total Current Liabilities | $2.39M | $2.45M | $2.33M | $2.21M | $1.96M | $1.99M |
| Total Liabilities | $4.54M | $4.62M | $4.43M | $4.24M | $4.00M | $6.06M |
| Common Stock | $314.72K | $311.88K | $308.63K | $307.96K | $305.68K | $302.87K |
| Retained Earnings | $-58.84M | $-58.42M | $-57.50M | $-57.26M | $-55.47M | $-57.33M |
| Total Stockholders Equity | $-3.06M | $-3.17M | $-2.95M | $-2.85M | $-2.51M | $-4.75M |
| Total Liabilities & Equity | $1.49M | $1.45M | $1.48M | $1.39M | $1.49M | $1.31M |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $-422.55K | $-1.16M | $-243.83K | $-1.79M | $1.87M | $-1.50M |
| Depreciation & Amortization | $127.44K | $96.02K | $29.93K | $29.66K | $89.14K | $59.47K |
| Change in Payables | $-49.37K | - | $12.61K | $214.29K | $-13.66K | $-4.94K |
| Operating Cash Flow | $-452.69K | $-298.72K | $13.42K | $-212.01K | $-791.41K | $-543.38K |
| Capital Expenditure | $68.90K | $136.15K | $104.63K | - | - | - |
| Investing Cash Flow | $-127.16K | $-193.30K | $-154.63K | $-85.56K | $-30.23K | $-19.82K |
| Stock Issued | $435.00K | $260.00K | - | - | - | - |
| Financing Cash Flow | $626.25K | $451.25K | $100.00K | $197.00K | $930.00K | $930.00K |
| Net Change in Cash | $46.40K | $-40.77K | $-41.21K | $-100.57K | $108.36K | $366.80K |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | - | - | - | - |
| Operating Expenses | $836.25K | - | $2.43M | - |
| Research & Development | $485.68K | - | $1.31M | - |
| Operating Income | $-836.25K | - | $-2.43M | - |
| Other Income/Expense | $5.00 | - | $7.00 | - |
| Income Tax Expense | - | - | - | - |
| Net Income | $-422.55K | $-548.82K | $-1.59M | - |
| Basic EPS | -0.00 | - | -0.01 | - |
| Diluted EPS | -0.00 | - | -0.01 | - |
| Basic Shares Outstanding | $312.17M | - | $310.84M | - |
| Diluted Shares Outstanding | $312.17M | - | $310.84M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $95.19K | $48.80K |
| Total Current Assets | $106.64K | $81.29K |
| Property Plant & Equipment | $585.41K | $539.65K |
| Total Assets | $1.49M | $1.39M |
| Total Current Liabilities | $2.39M | $2.21M |
| Total Liabilities | $4.54M | $4.24M |
| Common Stock | $314.72K | $307.96K |
| Retained Earnings | $-58.84M | $-57.26M |
| Total Stockholders Equity | $-3.06M | $-2.85M |
| Total Liabilities & Equity | $1.49M | $1.39M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-422.55K | $-548.82K | $-1.59M | - |
| Depreciation & Amortization | - | - | $127.44K | - |
| Change in Payables | - | - | $-49.37K | - |
| Operating Cash Flow | - | - | $-452.69K | - |
| Capital Expenditure | - | - | $68.90K | - |
| Investing Cash Flow | - | - | $-127.16K | - |
| Stock Issued | - | - | $435.00K | - |
| Financing Cash Flow | - | - | $626.25K | - |
| Net Change in Cash | - | - | $46.40K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.